Naveen Dakappagari
- Immunology top 5%
- Molecular Biology
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Neurology top 10%
- Co-authors
- Pravin T. P. KaumayaKatherine S. BowdishAnke Kretz-RommelFenghua QinDayang WuSusan J. FaasVernon C. StevensPierre L. Triozzi
- Topics
- Immunotherapy and Immune Responses (12 papers)Cancer Immunotherapy and Biomarkers (10 papers)CAR-T cell therapy research (8 papers)
- Cited by
- ImmunologyOncologyNeurology
- Partner nations
- United StatesSwitzerlandNetherlands
In The Last Decade
Naveen Dakappagari
32 papers receiving 902 citations
Peers
Comparison fields: 5 of 83
- Immunology 542
- Molecular Biology 430
- Oncology 292
- Radiology, Nuclear Medicine and Imaging 191
- Neurology 69
Countries citing papers authored by Naveen Dakappagari
This map shows the geographic impact of Naveen Dakappagari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naveen Dakappagari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naveen Dakappagari more than expected).
Fields of papers citing papers by Naveen Dakappagari
This network shows the impact of papers produced by Naveen Dakappagari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naveen Dakappagari. The network helps show where Naveen Dakappagari may publish in the future.
Co-authorship network of co-authors of Naveen Dakappagari
This figure shows the co-authorship network connecting the top 25 collaborators of Naveen Dakappagari. A scholar is included among the top collaborators of Naveen Dakappagari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naveen Dakappagari. Naveen Dakappagari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 11 | |
| 4 | 1 | |
| 5 | 25 | |
| 6 | 37 | |
| 7 | 1 | |
| 8 | 20 | |
| 9 | 19 | |
| 10 | 49 | |
| 11 | 71 | |
| 12 | 141 | |
| 13 | 39 | |
| 14 | 18 | |
| 15 | 15 | |
| 16 | 44 | |
| 17 | 66 | |
| 18 | 23 | |
| 19 | Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine. | 96 |
| 20 | 38 |
About Naveen Dakappagari
Naveen Dakappagari is a scholar working on Immunology, Oncology and Physiology, having authored 32 papers that have together received 919 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (10 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Immunology (542 citations), Oncology (292 citations) and Neurology (69 citations). Naveen Dakappagari has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Pravin T. P. Kaumaya, Katherine S. Bowdish, Anke Kretz-Rommel, Fenghua Qin, Dayang Wu, Susan J. Faas, Vernon C. Stevens, Pierre L. Triozzi, Toshiaki Maruyama and Martha A. Wild. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.